237 filings
Page 2 of 12
8-K
ghi 81tg0ea9f3c7jltd
6 Jun 18
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
85ta38algr ypz0zrz
25 Apr 18
Results of Operations and Financial Condition
12:00am
8-K
airkc
27 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
48lw 13g0jwgjkmid
27 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
prcjb lzu8ygdfxz
26 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
cba3jcu
21 Feb 18
The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results
12:00am
8-K
g9rr2h5otw 7f6wl54fl
6 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
bmjpeofsigdsd
11 Jan 18
Completion of Acquisition or Disposition of Assets
12:00am
8-K
ma5 dem225d2xp
5 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
vu97v17o isbhd
4 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
g1kqa7zqdfrx ww6hu7
15 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
83kfg74 4g0w4xz7mk
25 Oct 17
Results of Operations and Financial Condition
12:00am
8-K/A
o9otmwi9 wpu6s
20 Oct 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
rsb 2np9iaef
9 Aug 17
Results of Operations and Financial Condition
12:00am
8-K
irrorzh
2 Jun 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
ecyp eed4utren
1 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
fd0qgoirvfkbx0 kbh28
19 May 17
United States District Court District of New Jersey
12:00am
8-K
z2tr916z7 ak
26 Apr 17
The Medicines Company Reports First-Quarter 2017 Financial Results
12:00am
8-K
wh3d6p0x fag17
31 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
peq9wd o0j00
17 Mar 17
The Medicines Company and Alnylam Pharmaceuticals Report Positive Final Results from ORION-1 Phase II Study of Inclisiran
12:00am